Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.51) by 3.92 percent. This is a 12.77 percent decrease over losses of $(0.47) per share from the same period last year.
Elon Musk’s Tesla Adds Airbnb Co-founder Joe Gebbia To Its Board: Here’s The Fine Print
Tesla Inc. (NASDAQ: TSLA) has added Airbnb Inc (NASDAQ: ABNB) co-founder Joe Gebbia to its Board of Directors with effect from September 25, the company said in a statement.
